WELCOME TO
ROCKWELL RUPRAJAT COMPLIANCE CONSULTANCY

"Rockwell Ruprajat Compliance Consultancy" multidisciplinary team of highly experienced In Pharmaceutical Manufacturing (all type of OSD, Injection, vaccine, hormones') and industry expert SMEs has offered Mfg. & Quality compliance, regulatory affairs, and technical services to clients around the pharmaceutical world.
Rockwell provide supportive arms to build your pharmaceutical business, in Mfg. compliance with US-FDA , MHRA, ANVISA, TGA, MCC, China-FDA, JP-FDA or other all country regulatory bodies.
We offer world's best investigations techniques to solve your manufacturing problems with scientifically & proactively without Mfg cost impact. We treat each problem as an opportunity to grab possibility of improvements of Business to make affordable product quality and increase patient safety with trust.
Contact us to learn how partnership with Rockwell, We can provide an extra layer of protection for your business.
As a Rockwell Consultancy We believe in "Quality with Trust"

ABOUT ROCKWELL

Rockwell Ruprajat Compliance Consultancy group is devoted to blessings of Guru Rup-muniji or Rup rajat. We inspired from Jainism which is a religion of extreme legalism, for one attains his own salvation...

OUR SERVICES

Rockwell Ruprajat Compliance Consultancy offers a full portfolio of capabilities to deliver measurable results for clients as they prevent and resolve compliance problems and develop new products...

OUR BLOG

Our blogs feature and report on the latest news and trends in the industry...

OUR LATEST BLOG

HAPPY HOLIDAYS FROM US TO YOU!

December 20, 2018

To all of our readers – Have a happy holiday season and a very happy, healthy, and prosperous New Year. The Lachman blog will be taking a break over the holiday starting Friday...

RICKI CHASE PUBLISHES ARTICLE IN MEDTECH INSIGHT

December 18, 2018

Ricki Chase, Director, Compliance Practice, authored an article published in Medtech Insight, "How Device Makers Can Leverage FDA Data to Uncover The Agency's Current Thinking...

FDA WITHDRAWS PROPOSED LABELING RULE – FINALLY!

December 20, 2018

After just over five years, the FDA is officially withdrawing its controversial proposed labeling rule for generic drugs. The advance publication notice in the Federal Register can be found...

MAKE AN REGISTRATION

Rockwell will provide the opportunity to registered professional first with confidential information.

© Copyright All Rights Reserved. | Design & Developed By MWT